n-3 polyunsaturated fatty acids in heart failure: Mechanisms and recent clinical evidence

Cellular and Molecular Biology

Volumn 56, Issue 1, 2010, Pages 110-130

  Marchioli, R ^a   Silletta, M G ^a   Levantesi, G ^a   Pioggiarella, R ^a   Tognoni, G ^a  

^a Santa Maria Imbaro   (Italy)

Author keywords

Arrhythmias; Atherothrombosis; Cardiac haemodinamics; Heart failure; Inflammation; n 3 PUFA

Indexed keywords

BLOOD CLOTTING FACTOR; LINOLENIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE COURSE; DRUG MECHANISM; EVIDENCE BASED MEDICINE; FIBRINOLYSIS; HEART ARRHYTHMIA; HEART FAILURE; HEART HEMODYNAMICS; HEART VENTRICLE HYPERTROPHY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MORTALITY; NONHUMAN; OXIDATIVE STRESS; SUDDEN DEATH; THROMBOCYTE; THROMBOSIS; TREATMENT OUTCOME; ATHEROSCLEROSIS; CARDIOMEGALY; CHRONIC DISEASE; DIET SUPPLEMENTATION; DRUG EFFECT; ENERGY METABOLISM; HOSPITALIZATION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION;

DELLA;

ARRHYTHMIAS, CARDIAC; ATHEROSCLEROSIS; CARDIOMEGALY; CHRONIC DISEASE; DIETARY SUPPLEMENTS; ENERGY METABOLISM; FATTY ACIDS, OMEGA-3; FIBRINOLYSIS; HEART FAILURE; HOSPITALIZATION; HUMANS; INFLAMMATION; OXIDATIVE STRESS; PLATELET AGGREGATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOSIS;

EID: 77953626362     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T884     Document Type: Article

References (253)

1. Abeywardena, M.Y. and Head, R.J., Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc. Res. 2001, 52:361-371.
2. Adair, C.D., Sanchez-Ramos, L., Briones, D.L. and Ogburn, P. Jr., The effect of high dietary n-3 fatty acid supplementation on angiotensin II pressor response in human pregnancy. Am. J. Obstet. Gynecol. 1996, 175:688-691.
3. Aghababian, R.V., Acutely decompensated heart failure: opportunities to improve care and outcomes in the emergency department. Rev. Cardiovasc. Med. 2002, 3:S3- S9.
4. Akbar, M. and Kim, H.Y., Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J. Neurochem. 2002, 82:655-665.
5. Al Makdessi, S., Brandle, M., Ehrt, M., Sweidan, H. and Jacob, R., Myocardial protection by ischemic preconditioning: the influence of the composition of myocardial phospholipids. Mol. Cell. Biochem. 1995, 145:69-73.
6. Albert, C.M., Campos, H., Stampfer, M.J., Ridker, P.M., Manson, J.E., Willett, W.C. and Ma, J., Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 2002, 346: 1113-1118.
7. Albert, C.M., Hennekens, C.H., O'Donnell, C.J., Ajani, U.A., Carey, V.J., Willett, W.C., Ruskin, J.N. and Manson, J.E., Fish consumption and risk of sudden cardiac death. JAMA 1998, 279:23-28.
8. American Heart Association. Heart and Stroke Facts. Statistical Supplement. American Heart Association 1998
9. American Heart Association. Heart and Stroke Facts: 2005 Statistical Update. Dallas, Texas: American Heart Association; 2005
10. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N.A. and Serhan, C.N., Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 2005, 201:713-722.
11. Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., Campana, C., Perini, G., Deorsola, A., Masotti, G., Tavazzi, L. and Maggioni, A.P., Italian Network on Congestive Heart Failure Investigators. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am. Heart. J. 2002, 143:398-405.
12. Bang, H.O., Dyerberg, J. and Hjoorne, N., The composition of food consumed by Greenland Eskimos. Acta Med. Scand. 1976, 200:69-73.
13. Barcelli, U., Glas-Greenwalt, P. and Pollak, V.E., Enhancing effect of dietary supplementation with omega-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb. Res. 1985, 39:307-312.
14. Bayon, Y., Croset, M., Daveloose, D., Guerbette, F., Chirouze, V., Viret, J., Kader, J.C. and Lagarde, M., Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors. J. Lipid Res. 1995, 36:47-56.
15. Billman, G.E., Hallaq, H. and Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc. Natl. Acad Sci. U S A. 1994, 91:4427-4430.
16. Biscione, F., Totteri, A., De Vita, A., Lo Bianco, F. and Altamura, G., Effect of omega-3 fatty acids on the prevention of atrial arrhythmias. Ital Heart J Suppl 2005, 6: 53-59.
17. Braunwald, E. and Bristow, M.R., Congestive heart failure: fifty years of progress. Circulation 2000; 102:IV14-23.
18. Bristow, M.R., beta-adrenergic receptor blockade in chronic heart failure. Circulation 2000, 101:558-569.
19. Brouwer, I.A., Zock, P.L., Camm, A.J., Bocker, D., Hauer, R.N., Wever, E.F., Dullemeijer, C., Ronden, J.E., Katan, M.B., Lubinski, A., Buschler, H. and Schouten, E.G., SOFA Study Group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 2006, 295:2613-2619.
20. Bucher, H.C., Hengstler, P., Schindler, C. and Meier, G., N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am. J. Med. 2002, 112:298-304.
21. Burdge, G., Alpha-linolenic acid metabolism in men and women: nutritional and biologicalimplications. Curr. Opin. Clin. Nutr. Metab. Care. 2004, 7:137-144.
22. Burr, M.L., Ashfield-Watt, P.A., Dunstan, F.D., Fehily, A.M., Breay, P., Ashton, T., Zotos, P.C., Haboubi, N.A. and Elwood P.C., Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur. J. Clin. Nutr. 2003, 57:193-200.
23. Burr, M.L., Fehily, A.M., Gilbert, J.F., Rogers, S., Holliday, R.M., Sweetnam, P.M., Elwood, P.C. and Deadman, N.M., Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2:757-761.
24. Calò, L., Bianconi, L., Colivicchi, F., Lamberti, F., Loricchio, M.L., de Ruvo, E., Meo, A., Pandozi, C., Staibano, M. and Santini, M., N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005, 45: 1723-1728.
25. Caughey, G.E., Mantzioris, E., Gibson, R.A., Cleland, L.G. and James, M.J., The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr. 1996, 63:116-122.
26. Caughey, G.E., Pouliot, M., Cleland, L.G. and James, M.J., Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. J. Immunol. 1997, 158:351-358.
27. Charnock, J.S., McLennan, P.L. and Abeywardena, M.Y., Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol. Cell. Biochem. 1992, 116:19-25.
28. Chen, L.Y., Jokela, R., Li, D.Y., Bavry, A.A., Sandler, H., Sjoquist, M., Saldeen, T., Mehta, J.L. and Bowry, A., Effect of stable fish oil on arterial thrombogenesis, platelet aggregation, and superoxide dismutase activity. J. Cardiovasc. Pharmacol. 2000, 35:502-505.
29. Chen, L.Y., Lawson, D.L. and Mehta, J.L., Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor. Thromb. Res. 1994, 76:317-322.
30. Chin, J.P., Gust, A.P., Nestel, P.J. and Dart, A.M., Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993, 21:22-28.
31. Christensen, J.H., Gustenhoff, P., Korup, E., Aaroe, J., Toft, E., Moller, J., Rasmussen, K., Dyerberg, J. and Schmidt, E.B., Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 1996, 312:677-678.
32. Christensen JH. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. Dan Med Bull 2003, 50: 347-367.
33. Christensen, J.H., Korup, E., Aarøe, J., Toft, E., Møller, J., Rasmussen, K., Dyerberg, J. and Schmidt, E.B., Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventriculardysfunction. Am. J. Cardiol. 1997, 79:1670-1673.
34. CIBIS-II. Investigator and Committees. The cardiac insufficiency bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999, 353:9-13.
35. Cleland, J.G., Daubert, J.C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L. and Tavazzi, L., Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 2005, 352:1539-1549.
36. Cobiac, L., Clifton, P.M., Abbey, M., Belling, G.B. and Nestel, P.J., Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males. Am. J. Clin. Nutr. 1991, 53:1210-1216.
37. Coker, S.J., Parratt, J.R., Ledingham, I.M. and Zeitlin, I.J., Evidence that thromboxane contributes to ventricular fibrillation induced by reperfusion of the ischaemic myocardium. J. Mol. Cell. Cardiol. 1982, 14:483-485.
38. Collie-Duguid, E.S. and Wahle, K.W., Inhibitory effect of fish oil N-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem. Biophys. Res. Commun. 1996, 220:969-974.
39. Dallongeville, J., Bauge, E., Tailleux, A., Peters, J.M., Gonzalez, F.J., Fruchart, J.C. and Staels, B., Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil. J. Biol. Chem. 2001, 276:4634-4639.
40. Dallongeville, J., Yarnell, J., Ducimetiere, P., Arveiler, D., Ferrieres, J., Montaye, M., Luc, G., Evans, A., Bingham, A., Hass, B., Ruidavets, J.B. and Amouyel, P., Fish consumption is associated with lower heart rates. Circulation 2003, 108:820-825.
41. Das, U.N., Beneficial effect of eicosapentaenoic and docosahexaenoic acids in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leukot. Essent. Fatty Acids 1994, 51:207-213.
42. Daviglus, M.L., Stamler, J., Orencia, A.J., Dyer, A.R., Liu, K., Greenland, P., Walsh, M.K., Morris, D. and Shekelle, R.B., Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med. 1997, 336:1046-1053.
43. De Caterina, R. and Libby, P., Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 1996, 31:S57-63.
44. De Caterina, R., Cybulsky, M.I., Clinton, S.K., Gimbrone, M.A. Jr., and Libby, P., The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. 1994, 14:1829-1836.
45. De Caterina, R., Liao, J.K. and Libby, P., Fatty acid modulation of endothelial activation. Am. J. Clin. Nutr. 2000, 71:213S-223S.
46. De Caterina, R., Giannessi, D., Mazzone, A., Bernini, W., Lazzerini, G., Maffei, S., Cerri, M., Salvatore, L. and Weksler, B., Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery. Circulation 1990, 82:428-438.
47. Dehmer, G.J., Popma, J.J., van den Berg , E.K., Eichhorn, E.J., Prewitt, J.B., Campbell, W.B,. Jennings, L., Willerson, J.T. and Schmitz, J.M., Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N. Engl. J. Med. 1988, 319:733-740.
48. Demaison, L., Blet, J., Sergiel, J.P., Gregoire, S. and Argaud, D., Effect of dietary polyunsaturated fatty acids on contractile function of hearts isolated from sedentary and trained rats. Reprod Nutr. Dev. 2000, 40:113-125.
49. Demoz, A. Willumsen, N. and Berge, R.K., Eicosapentaenoic acid at hypotriglyceridemic dose enhances the epatic antioxidant defense in mice. Lipids 1992, 27:968-971.
50. Den Ruijter, H.M., Berecki, G., Verkerk, A.O., Bakker, D., Baartscheer, A., Schumacher, C.A., Belterman, C.N., de Jonge, N., Fiolet, J.W., Brouwer, I.A. and Coronel, R., Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation 2008, 117:536-544.
51. Denys, A., Hichami, A. and Khan, N.A., Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. J. Lipid Res. 2001, 42:2015-2020.
52. Denys, A., Hichami, A. and Khan, N.A., Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. Mol. Cell. Biochem. 2002, 232:143-148.
53. Denys, A., Hichami, A., Maume, B. and Khan, N.A., Docosahexaenoic acid modulates phorbol ester-induced activation of extracellular signal-regulated kinases 1 and 2 in NIH/3T3 cells. Lipids 2001, 36:813-818.
54. Department of Health and Human Services, US Food and Drug Administration. Substances affirmed as generally recognized as safe: menhaden oil. Federal Register. June 5, 1997. Vol. 62, No. 108: pp 30751-30757. 21 CFR Part 184 [Docket No. 86G-0289]. Available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=1997_register &docid=fr05jn97-5. Accessed October 3, 2002.
55. Diep, Q.N., Touyz, R.M. and Schiffrin, E.L., Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 2000, 36:851-855.
56. Dolecek, T.A. and Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World. Rev. Nutr. Diet. 1991, 66:205-216.
57. Eichhorn, E.J. and Bristow, M.R., Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 1996, 94:2285-2296.
58. Emken, E.A., Adlof, R.O. and Gulley, R.M., Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim. Biophys. Acta. 1994, 1213: 277-288.
59. Endres, S., Ghorbani, R., Kelley, V.E., Georgilis, K., Lonnemann, G., van der Meer, J.W., Cannon, J.G., Rogers, T.S., Klempner, M.S. and Weber, P.C., The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 1989, 320:265-271.
60. Engler, M.M., Engler, M.B., Goodfriend, T.L., Ball, D.L., Yu, Z., Su, P. and Kroetz, D.L., Docosahexaenoic acid is an antihypertensive nutrient that affects aldosterone production in SHR. Proc Soc. Exp. Biol. Med. 1999, 221:32-38.
61. Ernst, E., Effects of n-3 fatty acids on blood rheology. J. Intern. Med. Suppl. 1989, 731:129-132.
62. Ferrier, G.R. and Howlett, S.E., Cardiac excitation- contraction coupling: role of membrane potential in regulation of contraction. Am. J. Physiol. Heart Circ. Physiol. 2001, 280: H1928-1944.
63. Ferrier, G.R., Redondo, I., Zhu, J. and Murphy, M.G., Differential effects of docosahexaenoic acid on contractions and L-type Ca2+ current in adult cardiac myocytes. Cardiovasc. Res. 2002, 54:601-610.
64. Fisher, M., Levine, P.H., Weiner, B.H., Johnson, M.H., Doyle, E.M, Ellis, P.A. and Hoogasian, J.J., Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am. J. Clin. Nutr. 1990, 51:804-808.
65. Flather, M.D., Yusuf, S., Køber, L., Pfeffer, M., Hall, A., Murray, G., Torp-Pedersen, C., Ball, S., Pogue, J., Moyé, L. and Braunwald, E., Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000, 355:1575-1581.
66. Fonarow, G.C., Yancy, C.W. and Heywood , J.T., Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. Arch. Intern. Med. 2005, 165:1469-1477.
67. Fox, K., Ford, I., Steg, P.G., Tendera, M., Robertson, M. and Ferrari, R., BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008, 372:817-821.
68. Fox, P.L. and DiCorleto, P.E., Fish oils inhibit endothelial cell production of platelet-derived growth factor like protein. Science 1988, 241:453-456.
69. Freeman, L.M., Rush, J.E., Kehayias, J.J., Ross, J.N. Jr, Meydani, S.N., Brown, D.J., Dolnikowski, G.G., Marmor, B.N., White, M.E., Dinarello, C.A. and Roubenoff, R., Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J. Vet. Intern. Med. 1998, 12:440-448.
70. Geelen, A., Brouwer, I.A., Schouten, E.G., Maan, A.C., Katan, M.B. and Zock, P.L., Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr 2005, 81: 416-420.
71. Geelen, A., Brouwer, I.A., Zock, P.L., Kors, J.A., Swenne, C.A., Katan, M.B. and Schouten, E.G., N-3 fatty acids do not affect electrocardiographic characteristics of healthy men and women. J. Nutr. 2002, 132: 3051-3054.
72. Geleijnse, J.M., Giltay, E.J., Grobbee, D.E., Donders, A.R. and Kok, F.J., Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 2002, 20:1493-1499.
73. Gerbi, A. and Maixent, J.M., Fatty acid-induced modulation of ouabain responsiveness of rat Na, K-ATPase isoforms. J. Membr. Biol. 1999, 168:19-27.
74. Gerbi, A., Barbey, O., Raccah, D., Coste, T., Jamme, I., Nouvelot, A., Ouafik L, Levy, S., Vague, P. and Maixent, J.M., Alteration of Na,K-ATPase isoenzymes in diabetic cardiomyopathy: effect of dietary supplementation with fish oil (n-3 fatty acids) in rats. Diabetologia 1997, 40:496-505.
75. Goldman, D.W., Pickett, W.C. and Goetzl, E.J., Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem. Biophys. Res. Commun. 1983, 117:282-288.
76. Goodnight, S.H. Jr., Harris, W.S., Connor, W.E. and Illingworth, D.R., Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 1982, 2:87-113.
77. Goodnight, S.H. Jr., Harris, W.S., Connor, W.E., The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood 1981, 58:880-885.
78. Grimsgaard, S., Bønaa, K.H., Hansen, J.B. and Myhre, E.S., Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am. J. Clin. Nutr. 1998, 68:52-59.
79. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455.
80. Hagve, T.A., Gronn, M. and Christophersen, B.O., The decrease in osmotic fragility of erythrocytes during supplementation with n-3 fatty acids is a transient phenomenon. Scand. J. Clin. Lab. Invest. 1991, 51:493-495.
81. Hallaq, H., Sellmayer, A., Smith, T.W. and Leaf, A., Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. U S A 1990, 87:7834-7838.
82. Hallaq, H., Smith, T.W. and Leaf, A., Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc. Natl. Acad. Sci. U S A 1992, 89:1760-1764.
83. Hansen, J., Grimsgaard, S., Nordoy, A. and Bonaa, KH., Dietary supplementation with highly purified eicosapentaenoic acid and docosahexaenoic acid does not influence PAI-1 activity. Thromb. Res. 2000, 98:123-132.
84. Hansen, J.B., Lyngmo, V., Svensson, B. and Nordoy, A., Inhibition of exercise-induced shortening of bleeding time by fish oil in familial hypercholesterolemia (type IIa). Arterioscler. Thromb. 1993, 13:98-104.
85. Hansen, J.B., Olsen, J.O., Wilsgard, L. and Osterud, B., Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J. Intern. Med. Suppl. 1989, 731:133-139.
86. Harper, C.R. and Jacobson, T.A., Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am. J. Cardiol. 2005, 96:1521-1529.
87. Harris, W.S., Connor, W.E., Illingworth, D.R., Rothrock, D.W. and Foster, D.M., Effects of fish oil on VLDL triglyceride kinetics in humans. J. Lipid. Res. 1990, 31:1549-1558.
88. Harris, W.S., Connor, W.E., Inkeles, S.B. and Illingworth, D.R., Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia. Metabolism 1984, 33:1016-1019.
89. Harris, W.S., Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am. J. Cardiol. 2007, 99:44C-46C.
90. Harris, W.S., Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, L.L., Appel, L.J., Engler, M.M., Engler, M,B. and Sacks, F., Omega-6 Fatty Acids and Risk for Cardiovascular Disease. Circulation 2009, 119: 0-0 [Epub ahead of print]
91. Harris, W.S., Rambjor, G.S., Windsor, S.L. and Diederich, D., n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am. J. Clin. Nutr. 1997, 65:459-464.
92. He, K., Song ,Y., Daviglus, M.L., Liu, K., Van Horn, L., Dyer, A.R. and Greenland, P., Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004, 109:2705-2711.
93. Hellsten, G., Boman, K., Saarem, K., Hallmans, G. and Nilsson, T.K., Effects on fibrinolytic activity of corn oil and a fish oil preparation enriched with omega-3- polyunsaturated fatty acids in a long-term study. Curr. Med. Res. Opin. 1993, 13:133-139.
94. Herrmann, W., Biermann, J. and Kostner, G.M., Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease. Am. J. Cardiol. 1995, 76:459-462.
95. Hjalmarson, A., Goldstein ,S., Fagerberg, B. Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vitovec, J., Aldershvile, J., Halinen, M., Dietz, R., Neuhaus, K.L., Janosi, A., Thorgeirsson, G., Dunselman, P.H., Gullestad, L., Kuch, J., Herlitz,J., Rickenbacher, P., Ball, S., Gottlieb, S.and Deedwania, P., Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000, 283:1295-1302.
96. Hock, C.E., Beck, L.D., Bodine, R.C. and Reibel, D.K., Influence of dietary n-3 fatty acids on myocardial ischemia and reperfusion. Am. J. Physiol. 1990, 259:H1518-1526.
97. Hock, C.E., Holahan, M.A. and Reibel, D.K., Effect of dietary fish oil on myocardial phospholipids and myocardial ischemic damage. Am. J. Physiol. 1987, 252:554-560.
98. Hostmark, A.T., Bjerkedal, T., Kierulf, P., Flaten, H. and Ulshagen, K., Fish oil and plasma fibrinogen. BMJ 1988, 297:180-181.
99. Hu, F.B., Bronner, L., Willett,W.C., Stampfer, M.J., Rexrode, K.M., Albert, C.M., Hunter, D. and Manson, J.E., Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002, 287:1815-1821.
100. Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S., Ganiats, T.G., Jessup, M., Konstam, M.A., Mancini, D.M., Michl, K., Oates, J.A., Rahko, P.S., Silver, M.A., Stevenson, L.W., Yancy, C.W., Antman, E.M., Smith, S.C. Jr., Adams, C.D., Anderson, J.L., Faxon, D.P., Fuster, V., Halperin, J.L., Hiratzka, L.F., Jacobs, A.K., Nishimura, R., Ornato, J.P., Page, R.L. and Riegel, B., ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol. 2005, 46:e1-82.
101. Hunt, S.A., Baker, D.W., Chin, M.H., Cinquegrani, M.P., Feldman, A.M., Francis, G.S., Ganiats, T.G., Goldstein, S., Gregoratos, G., Jessup, M.L., Noble, R.J., Packer, M., Silver, M.A., Stevenson, L.W., Gibbons, R.J., Antman, E.M., Alpert, J.S., Faxon, D.P., Fuster, V., Gregoratos, G., Jacobs, A.K., Hiratzka, L.F., Russell, R.O.and Smith, S.C. Jr., ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelinesm(Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001, 104:2996-3007.
102. Iritani, N., Inoguchi, K., Endo, M., Fukuda, E. and Morita, M., Identification of shellfish fatty acids and their effects on lipogenic enzymes. Biochim. Biophys. Acta 1980, 618:378-382.
103. Iso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., Kokubo, Y. and Tsugane, S., Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006, 113:195-202.
104. Jump, D.B. and Clarke, S.D., Regulation of gene expression by dietary fat. Annu. Rev. Nutr. 1999, 19:63-90.
105. Kaminski, W.E., Jendraschak, E., Kiefl, R. and von Schacky, C., Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 1993; 81:1871-1879.
106. Kang ,J.X. and Leaf, A., Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am. J. Clin. Nutr. 2000, 71:202S-207S.
107. Kang, J.X. and Leaf, A., Antiarrhythmic effects of polyunsaturated fatty acids. Recent studies. Circulation 1996, 94:1774-1780.
108. Kang, J.X. and Leaf, A., Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. U S A 1994, 91:9886-9890.
109. Kang, J.X. and Leaf, A., Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes. Eur. J. Pharmacol. 1996, 297:97-106.
110. Kang, J.X., Xiao, Y.F. and Leaf, A., Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. U S A 1995, 92:3997-4001.
111. Katz, A,M., Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management. Philadelphia, PA: Lippincott Williams & Wilkins, 2000
112. Kenny, D., Warltier, D.C., Pleuss, J.A., Hoffmann, R.G., Goodfriend, T.L., Egan, and B.M., Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am. J. Cardiol. 1992, 70:1347-1352.
113. Khalfoun, B., Thibault, F., Watier, H., Bardos, P. and Lebranchu, Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv. Exp. Med. Biol. 1997, 400B:589-597.
114. Kim, D.N., Eastman, A., Baker, JE., Mastrangelo, A., Sethi, S., Ross, J.S., Schmee, J. and Thomas, W.A., Fish oil, atherogenesis, and thrombogenesis. Ann. N. Y. Acad. Sci. 1995, 748:474-480.
115. Kim, H.Y., Akbar, M., Lau, A. and Edsall, L., Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J. Biol. Chem. 2000, 275:35215-35223.
116. Kinoshita, I., Itoh, K., Nishida-Nakai, M., Hirota, H., Otsuji, S. and Shibata, N., Antiarrhythmic effects of eicosapentaenoic acid during myocardial infarction enhanced cardiac microsomal (Ca(2+)-Mg2+)-ATPase activity. Jpn. Circ. J. 1994, 58:903-912.
117. Knapp, H.R., Reilly, I.A., Alessandrini, P. and FitzGerald, G.A., In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N. Engl. J. Med. 1986, 314:937-942.
118. Kris-Etherton, P.M., Harris, W.S. and Appel, L.J., Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
119. Kromhout, D., Bosschieter, E.B. and de Lezenne Coulander, C., The inverse relation between fish consuption and 20 year mortality from coronary heart disease. N. Engl. J. Med. 1985, 312: 1205-1209.
120. Krum, H., The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005).Eur. Heart. J. 2005, 26:2472.
121. Kumar, G.S. and Das, U.N., Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot. Essent. Fatty Acids 1994, 50:331-334.
122. Leaf, A., Albert, C.M., Josephson, M., Steinhaus, D., Kluger, J., Kang, J.X., Cox, B., Zhang, H. and Schoenfeld, D. for the Fatty Acid Antiarrhythmia Trial Investigators. Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake. Circulation 2005, 112:2762-2768.
123. Leaf, A., Omega-3 fatty acids and prevention of ventricular fibrillation. Prostaglandins Leukot. Essent. Fatty Acid 1995, 52:197-198.
124. Leaf, A., The electrophysiological basis for the antiarrhythmic actions of polyunsaturated fatty acid. Eur. Heart J. 2001, 3:D98-D105.
125. Leaf, A., Xiao, Y.F., Kang, J.X. and Billman, G,E., Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacol Ther. 2003, 98:355-377.
126. Lehr, H.A., Hubner, C., Finckh, B., Nolte, D., Beisiegel, U., Kohlschutter, A. and Messmer, K.. Dietary fish oil reduces leukocyte/endothelium interaction following systemic administration of oxidatively modified low density lipoprotein. Circulation 1991, 84:1725-1731.
127. Lewis, R.A., Lee, T.H. and Austen, K.F., Effects of omega-3 fatty acids on the generation of products of the 5-lipoxygenase pathway. In: Health effects of polyunsaturated fatty acids in seafoods 1986, pp. 227-238.
128. Li, Y., Kang, J.X. and Leaf, A., Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. Prostaglandins 1997, 54:511-530.
129. Lo, C.J., Chiu, K.C., Fu, M., Lo, R. and Helton, S., Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J. Surg. Res. 1999, 82:216-221.
130. Lonergan, P.E., Martin, D.S., Horrobin, D.F. and Lynch, M.A., Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation. J. Biol. Chem. 2002, 277: 20804-20811.
131. Macchia, A., Levantesi, G., Franzosi, M.G., Geraci, E., Maggioni, A.P., Marfisi, R., Nicolosi, G.L., Schweiger, C., Tavazzi, L., Tognoni, G., Valagussa, F. and Marchioli, R., Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur. J. Heart. Fail. 2005, 7:904-909.
132. Maixent, J.M., Gerbi, A., Barbey, O., Lan, C., Jamme, I., Burnet, H., Nouvelot, A., Levy, S., Cozzone, P.J. and Bernard, M., Dietary fish oil promotes positive inotropy of ouabain in the rat heart. Am. J. Physiol. 1999, 277:H2290-2297.
133. Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M.G., Geraci, E., Levantesi, G., Maggioni, A.P., Mantini, L., Marfisi, R.M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G.L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C.and Valagussa, F., Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897-1903.
134. Marsh, J.B., Topping, D.L. and Nestel, P.J., Comparative effects of dietary fish oil and carbohydrate on plasma lipids and hepatic activities of phosphatidate phosphohydrolase, diacylglycerol acyltransferase and neutral lipase activities in the rat. Biochim. Biophys. Acta 1987, 922:239-243.
135. Mater, M.K., Thelen, A.P., Pan, D.A., and Jump, D.B., Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J Biol Chem. 1999, 274:32725-32732.
136. Mayer, K., Merfels, M., Muhly-Reinholz, M., Gokorsch, S., Rosseau, S., Lohmeyer, J., Schwarzer, N., Krull, M., Suttorp, N., Grimminger, F. and Seeger, W., Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am. J. Physiol. Heart. Circ. Physiol. 2002, 283:811-818.
137. McLennan, P.L., Abeywardena, M.Y. and Charnock, J.S., Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am. Heart J. 1988, 116:709-717.
138. McLennan, P.L., Abeywardena, M.Y. and Charnock, J.S., Reversal of the arrhythmogenic effects of long-term saturated fatty acid intake by dietary n-3 and n-6 polyunsaturated fatty acids. Am. J. Clin. Nutr. 1990, 51:53-58.
139. McLennan, P.L., Barnden, L.R., Bridle, T.M., Abeywardena, M.Y. and Charnock, J.S., Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc. Res. 1992, 26:871-877.
140. McLennan, P.L., Bridle, T.M., Abeywardena, M.Y. and Charnock, J.S., Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am. Heart. J. 1992, 123:1555-1561.
141. McLennan, P.L., Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am. J. Clin. Nutr. 1993, 57: 207-212.
142. McMillin, J.B., Bick, R.J. and Benedict, C.R., Influence of dietary fish oil on mitochondrial function and response to ischemia. Am. J. Physiol. 1992, 263:H1479-1485.
143. McVeigh, G.E., Brennan, G.M., Cohn, J.N., Finkelstein, S.M., Hayes, R.J. and Johnston, G.D., Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. 1994, 14:1425-1429.
144. Mehra, M.R., Lavie, C.J., Ventura, H.O. and Milani, R.V., Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J. Heart. Lung. Transplant. 2006, 25:834-838.
145. Mehta, J., Lawson, D. and Saldeen, T.J., Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. Am. Heart J. 1988, 116:1201-1206.
146. Meydani, S.N., Endres, S., Woods, M.M., Goldin, B.R., Soo, C., Morrill-Labrode, A., Dinarello, C.A. and Gorbach, S.L., Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J. Nutr. 1991, 121:547-555.
147. Mirnikjoo, B., Brown, S.E., Kim, H.F., Marangell, L.B., Sweatt, J.D. and Weeber, E.J., Protein kinase inhibition by omega-3 fatty acids. J. Biol. Chem. 2001, 276:10888-10896.
148. Miyazaki, M., Takemura, N., Watanabe, S., Hata, N., Misawa, Y. and Okuyama, H., Dietary docosahexaenoic acid ameliorates, but rapeseed oil and safflower oil accelerate renal injury in stroke-prone spontaneously hypertensive rats as compared with soybean oil, which is associated with expression for renal transforming growth factor-beta, fibronectin and renin. Biochim. Biophys. Acta 2000, 1483:101-110.
149. Mori, T.A., Puddey, I.B., Burke, V., Croft, K.D., Dunstan, D.W., Rivera, J.H. and Beilin, L.J., Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Redox. Rep. 2000, 5:45-46.
150. Mori, T.A., Watts, G.F., Burke, V., Hilme, E., Puddey, I.B. and Beilin, L,J., Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000, 102:1264-1269.
151. Mozaffarian, D., and Rimm, E.B., Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296:1885-1899.
152. Mozaffarian, D., Bryson, C.L., Lemaitre, R.N., Burke, G.L. and Siscovick, D.S., Fish intake and risk of incident heart failure. J. Am. Coll. Cardiol. 2005, 45: 2015-2021.
153. Mozaffarian, D., Geelen, A., Brouwer, I.A., Geleijnse, J.M., Zock, P.L. and Katan, M.B., Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005, 112:1945-1952.
154. Mozaffarian, D., Gottdiener, J.S. and Siscovick, D.S., Intake of tuna or other broiled or baked fish vs. fried fish and cardiac structure, function, and hemodynamics. Am. J. Cardiol. 2006, 97:216-222.
155. Mozaffarian, D., Lemaitre, R.N., Kuller, L.H., Burke, G.L., Tracy, R.P. and Siscovick, D.S., Cardiovascular Health Study Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003, 107:1372-1377.
156. Nair, S.S., Leitch, J., Falconer, J. and Garg, M.L., Cardiac (n-3) non-esterified fatty acids are selectively increased in fish oil-fed pigs following myocardial ischemia. J. Nutr. 1999, 129:1518-1523.
157. Nakayama, M., Fukuda, N., Watanabe, Y., Soma, M., Hu, W.Y., Kishioka, H., Satoh, C., Kubo, A. and Kanmatsuse , K., Low dose of eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-beta. J. Hypertens. 1999, 17:1421-1430.
158. Nelson, G.J., Schmidt, P.C. and Corash, L., The effect of a salmon diet on blood clotting, platelet aggregation and fatty acids in normal adult men. Lipids 1991, 26:87-96.
159. Nestel, P.J., Fish oil attenuates the cholesterol induced rise in lipoprotein cholesterol. Am. J. Clin. Nutr. 1986, 43:752-757.
160. Nestel, P.J., Connor, W.E., Reardon, M.F., Connor, S., Wong ,S. and Boston, R., Suppression by diets rich in fish oil of very low density lipoprotein production in man. J. Clin. Invest 1984, 74:82-89.
161. Nilsen, D.W., Dalaker, K., Nordoy, A., Osterud, B., Ingebretsen, O.C., Lyngmo, V., Almdahl, S., Vaage, J. and Rasmussen, K., Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery. Thromb. Haemost. 1991, 66:195-201.
162. Nitta, K., Uchida, K., Tsutsui, T., Honda, K., Kawashima, A., Yumura, W. and Nihei, H., Eicosapentaenoic acid inhibits mitogen-induced endothelin- 1 production and DNA synthesis in cultured bovine mesangial cells. Am. J. Nephrol. 1998, 18:164-170.
163. Novak, T.E., Babcock, T.A., Jho, D.H., Helton, W.S. and Espat, N.J., NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284:L84-89.
164. Oddis, C.V., Mayer, O.H. and Finkel, M.S., Inotropic, chronotropic, and radioligand binding characteristics of leukotriene B4 in cardiac myocyte, papillary muscle, and membrane preparations. Prostaglandins Leukot. Essent. Fatty Acids 1996, 54:223-228.
165. O'Keefe, J.H. Jr., Abuissa, H., Sastre, A., Steinhaus, D.M. and Harris, W.S., Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am. J. Cardiol. 2006, 97:1127-1130.
166. Omura, M., Kobayashi, S., Mizukami, Y., Mogami, K., Todoroki-Ikeda, N., Miyake, T.and Matsuzaki, M., Eicosapentaenoic acid (EPA) induces Ca(2{Thorn})-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett. 2001, 487:361-366.
167. Paige, J.A., Liao, R., Hajjar, R.J., Foisy, R.L., Cory, C.R., O'Brien, P.J. and Gwathmey, J.K., Effect of a high omega-3 fatty acid diet on cardiac contractile performance in Oncorhynchus mykiss. Cardiovasc. Res. 1996, 31:249-262.
168. Parratt, J.R., Coker, S.J. and Wainwright, C.L., Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion. J. Mol. Cell. Cardiol. 1987, 19:55-66.
169. Paulson, D.J., Smith, J.M., Zhao, J. and Bowman, J., Effects of dietary fish oil on myocardial ischemic/reperfusion injury of Wistar Kyoto and stroke- prone spontaneously hypertensive rats. Metabolism 1992, 41:533-539.
170. Pawlosky, R.J., Hibbeln, J.R., Novotny, J.A. and Salem, N. Jr., Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid Res. 2001, 42: 1257-1265.
171. Pellegrini, G., Totani, L., Di Santo, A., Piccoli, A., Tacconi, M.T., Donati, M.B. and Lorenzet, R., Supplementation-induced changes in polyunsaturated fatty acid membrane and plasma composition do not modify mononuclear cell procoagulant activity. Thromb. Res. 1993, 71:95-101.
172. Peoples, G.E., McLennan, P.L., Howe, P.R.and Groeller, H., Fish oil reduces heart rate and oxygen consumption during exercise. J. Cardiovasc. Pharmacol. 2008, 52:540-547.
173. Pepe, S. and McLennan, L., (n-3) Long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats. J. Nutr. 2007, 137:2377-2383.
174. Pepe, S. and McLennan, P.L., Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 2002, 105:2303-2308.
175. Pepe, S., Bogdanov, K., Hallaq, H., Spurgeon, H., Leaf, A. and Lakatta, E., Omega 3 polyunsaturated fatty acid modulates dihydropyridine effects on L-type Ca2+ channels, cytosolic Ca2+, and contraction in adult rat cardiac myocytes. Proc. Natl. Acad. Sci. U S A 1994, 91:8832-8836.
176. Phillipson, B.E., Rothrock ,D.W., Connor, W.E., Harris, W.S. and Illingworth, D.R., Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N. Engl. J. Med. 1985, 312:1210-1216.
177. Pound, E.M., Kang, J.X. and Leaf, A., Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J. Lipid Res. 2001, 42:346-351.
178. Purasiri, P., Murray, A., Richardson, S., Heys, S.D., Horrobin, D. and Eremin, O., Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin. Sci. (Lond) 1994, 87:711-717.
179. Radack, K., Deck, C. and Huster, G., Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study. Ann. Intern. Med. 1989, 111:757-758.
180. Radack, K., Deck, C. and Huster, G., The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic subjects. J. Am. Coll. Nutr. 1990, 9:352-357.
181. Radack, K.L., Deck, C.C. and Huster, G.A., n-3 fatty acid effects on lipids, lipoproteins, and apolipoproteins at very low doses: results of a randomized controlled trial in hypertriglyceridemic subjects. Am. J. Clin. Nutr. 1990, 51:599-605.
182. Raitt, M.H., Connor, W.E., Morris, C., Kron, J., Halperin, B., Chugh, S.S., McClelland, J., Cook, J., MacMurdy, K., Swenson, R., Connor , S.L., Gerhard, G., Kraemer, D.F., Oseran, D., Marchant, C., Calhoun, D., Shnider, R. and McAnulty, J., Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005, 293:2884-2891
183. Richard, D., Kefi, K., Barbe, U., Bausero, P. and Visioli, F., Polyunsaturated fatty acids as antioxidants. Pharmacol. Res. 2008, 57:451-455.
184. Rodrigo, G.C., Dhanapala, S. and Macknight, A.D., Effects of eicosapentaenoic acid on the contraction of intact, and spontaneous contraction of chemically permeabilized mammalian ventricular myocytes. J Mol. Cell. Cardiol. 1999, 31:733-743.
185. Rodriguez, B.L., Sharp, D.S., Abbott, R.D., Burchfiel, C.M., Masaki, K., Chyou, P.H., Huang ,B., Yano, K. and Curb, J.D., Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. The Honolulu Heart Program. Circulation 1996, 94:952-956.
186. Rustan, A.C., Christiansen, E.N. and Drevon, C.A., Serum lipids, hepatic glycerolipid metabolism and peroxisomal fatty acid oxidation in rats fed omega-3 and omega-6 fatty acids. Biochem. J. 1992, 283:333-339.
187. Rustan, A.C., Nossen, J.O., Christiansen, E.N. and Drevon, C.A., Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J. Lipid. Res. 1988, 29:1417-1426.
188. Saito, H., Chang, K.J., Tamura, Y. and Yoshida, S., Ingestion of eicosapentaenoic acid-ethyl ester renders rabbit LDL less susceptible to Cu2(+)-catalyzed-oxidative modification. Biochem. Biophys. Res. Commun. 1991, 175:61-67.
189. Sanders, T.A., Sullivan, D.R., Reeve, J. and Thompson, G.R., Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis 1985, 5:459-465.
190. Saynor, R., Verel, D. and Gillott, T., The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis 1984, 50:3-10.
191. Schmidt, E.B., Arnesen, H., Christensen, J.H., De Caterina, R., Rasmussen, L.H. and Kristensen, S.D., Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part I. Background, epidemiology, animal data, effects on risk factors and safety. Thromb. Res. 2005, 115:163-170.
192. Schmidt, E.B., Arnesen, H., Christensen, J.H., Rasmussen, L.H., Kristensen, S.D. and De Caterina, R., Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. Clinical trials and recommendations. Thromb. Res. 2005, 115:257-262.
193. Schmidt, E.B., Kristensen, S.D. and Dyerberg, J., The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery 1988, 15:316-329.
194. Schmidt, E.B., Varming, K., Ernst, E., Madsen, P. and Dyerberg, J., Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb. Haemost. 1990, 63:1-5.
195. Schocken, D.D., Benjamin ,E.J., Fonarow, G.C., Krumholz, H.M., Levy, D., Mensah, G.A., Narula, J., Shor, E.S., Young, J.B. and Hong, Y., Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008, 117: 2544-2565.
196. Sellmayer, A., Hrboticky, N., Weber, P.C., Lipids in vascular function. Lipids 1999, 34:S13-18.
197. Sellmayer, A., Witzgall, H., Lorenz, R.L. and Weber, P.C., Effects of dietary fish oil on ventricular premature complexes. Am. J. Cardiol. 1995, 76: 974-977.
198. Serhan, C.N., Clish, C.B., Brannon, J., Colgan, S.P., Chiang, N. and Gronert, K., Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 2000, 192:1197-1204.
199. Sethi, S., Eastman, A.Y. and Eaton, J.W., Inhibition of phagocyte-endothelium interactions by oxidized fatty acids: a natural anti-inflammatory mechanism?. J. Lab. Clin. Med. 1996, 128:27-38.
200. Shahar, E., Folsom, A.R., Wu, K.K., Dennis, B.H., Shimakawa, T., Conlan, M.G., Davis, C.E. and Williams, O.D., Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. 1993, 13:1205-1212.
201. Siddiqui, R.A., Shaikh, S.R., Kovacs, R., Stillwell, W. and Zaloga, G., Inhibition of phenylephrine-induced cardiac hypertrophy by docosahexaenoic acid. J. Cell. Biochem. 2004, 92:1141-1159.
202. Simopoulos, A.P. In: Dietary n-3 and n-6 fatty acids: biological effects and nutritional essentiality, Galli, C. (eds.), Plenum Press, New York, 1989, pp.391-402.
203. Simopoulos, A.P., Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin.Nutr. 1991, 54:438-463.
204. Singer, P. and Wirth, M., Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial. Prostaglandins Leukot Essent Fatty Acids 2004, 71: 153-159.
205. Siscovick, D.S., Raghunathan, T., King, I., Weinmann, S., Bovbjerg, V.E., Kushi, L., Cobb, L.A., Copass, M.K., Psaty, B.M., Lemaitre, R., Retzlaff, B., and Knopp, R.H., Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am.J. Clin. Nutr. 2000, 71:208S-212S.
206. Siscovick, D.S., Raghunathan, T.E., King, I., Weinmann, S., Wicklund, K.G., Albright, J., Bovbjerg, V., Arbogast, P., Smith, H. and Kushi, L.H., Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363-1367.
207. Smith, P., Arnesen, H., Opstad, T., Dahl, K.H. and Eritsland, J., Influence of highly concentrated n-3 fatty acids on serum lipids and hemostatic variables in survivors of myocardial infarction receiving either oral anticoagulants or matching placebo. Thromb. Res. 1989, 53:467-474.
208. Sullivan, D.R., Sanders, T.A., Trayner, I.M., and Thompson, G.R., Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil. Atherosclerosis 1986, 61:129-134.
209. Supari, F., Ungerer, T., Harrison, D.G. and Williams, J.K., Fish oil treatment decreases superoxide anions in the myocardium and coronary arteries of atherosclerotic monkeys. Circulation 1995, 91:1123-1128.
210. Suzukawa, M., Abbey, M., Howe, P.R. and Nestel, P.J., Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid. Res. 1995, 36:473-484.
211. Swann, P.G., Venton, D.L. and Le Breton, G.C., Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Lett. 1989, 243:244-246.
212. Takahashi, M., Tsuboyama-Kasaoka, N., Nakatani, T., Ishii, M., Tsutsumi, S., Aburatani, H. and Ezaki, O., Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 282:G338-348.
213. Takahashi, R., Okumura, K., Asai, T., Hirai, T., Murakami, H., Murakami, R., Numaguchi, Y.,Matsui, H., Ito, M. and Murohara, T., Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc. Res. 2005, 68:213-223.
214. Takimoto, G., Galang, J., Lee, G.K. and Bradlow, BA., Plasma fibrinolytic activity after ingestion of omega-3 fatty acids in human subjects. Thromb. Res. 1989, 54:573-582.
215. Tavazzi, L., Maggioni, A. P., Marchioli, R., Barlera, S., Franzosi, M. G., Latini, R., Lucci, D., Nicolosi, G. L., Porcu, M. and Tognoni, G., Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223-1230.
216. Tavazzi, L., Tognoni, G., Franzosi, M.G., Latini, R., Maggioni, A.P., Marchioli, R., Nicolosi, G.L. and Porcu, M., Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur. J. Heart. Fail. 2004, 6:635-641.
217. Terano, T., Shiina, T. and Tamura, Y., Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Lipids 1996; 31:S301-304.
218. Terano, T., Hirai, A., Hamazaki, T., Kobayashi, S., Fujita, T., Tamura, Y. and Kumagai, A., Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 1983, 46:321-331.
219. Thies, F., Garry, J.M., Yaqoob, P., Rerkasem, K., Williams, J., Shearman, C.P., Gallagher, P.J., Calder, P.C. and Grimble, R.F., Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361:477-485.
220. Tremoli, E., Eligini, S., Colli, S., Maderna, P., Rise, P., Pazzucconi, F., Marangoni, F., Sirtori, C.R., and Galli, C., n-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes. Arterioscler. Thromb. 1994, 14:1600-1608.
221. Vericel, E., Calzada, C., Chapuy, P. and Lagarde, M., The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis 1999, 147:187-192.
222. von Schacky, C. and Weber, P.C., Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J. Clin. Invest. 1985, 76:2446-2450.
223. von Schacky, C., Fischer, S. and Weber, P.C., Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J. Clin. Invest. 1985, 76:1626-1631.
224. Weber, C., Erl, W., Pietsch, A, Danesch, U. and Weber, PC., Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler. Thromb. Vasc Biol. 1995, 15:622-628.
225. Weber, P.C., Clinical studies on the effects of n-3 fatty acids on cells and eicosanoids in the cardiovascular system. J. Intern. Med. Suppl. 1989, 731:61-68.
226. Weber, P.C., Fischer, S., von Schaky, C., Lorenz, R. and Strasser, T., Dietary omega-3 polyunsaturated fatty acids eicosanoid formation in man. In: Health effects of polyunsaturated fatty acids in seafoods, Simopoulos, A.P., Kifer, R.R. and Martin, R.E., (eds.), Academic Press, Orlando, FL, 1986, pp. 49-60.
227. Weylandt, K.H., Kang, J.X. and Leaf, A., Polyunsaturated fatty acids exert antiarrhythmic actions as free acids rather than in phospholipids. Lipids 1996, 31:977-982.
228. Wigmore, S.J., Fearon, K.C,, Maingay, J.P. and Ross, J.A., Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin. Sci. (Lond). 1997, 92:215-221.
229. Wigmore, S.J., Ross, J.A., Falconer, J.S., Plester, C.E., Tisdale, M.J., Carter, D.C., Fearon, K.C., The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996, 12:S27-30.
230. Willumsen, N., Skorve, J., Hexeberg, S., Rustan, A.C. and Berge, R.K., The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis. Lipids 1993, 28:683-690.
231. Xiao, Y.F., Gomez, A.M., Morgan, J.P., Lederer, W.J. and Leaf, A., Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U S A 1997, 94:4182-4187.
232. Xiao, Y.F., Kang, J.X., Morgan, J.P. and Leaf, A., Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U S A 1995, 21:11000-11004.
233. Xiao, Y.F., Ke, Q., Chen, Y., Morgan, J.P. and Leaf, A., Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells. Biochem. Biophys. Res. Commun. 2004, 321:116-123.
234. Xiao, Y.F., Wright, S.N., Wang ,G.K, Morgan, J.P. and Leaf, A., Coexpression with beta(1)-subunit modifies the kinetics and fatty acid block of hH1(alpha) Na(+) channels. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H35-46.
235. Xiao, Y.F., Wright, S.N., Wang, G.K., Morgan, J.P. and Leaf, A., Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel. Proc. Natl. Acad. Sci. U S A 1998, 95:2680-2685.
236. Yamagishi, K., Iso, H., Date, C., Fukui, M., Wakai, K., Kikuchi, S., Inaba, Y., Tanabe, N. and Tamakoshi, A., Japan Collaborative Cohort Study for Evaluation of Cancer Risk Study Group. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J. Am. Coll. Cardiol. 2008, 52:988-996.
237. Yamagishi, K., Nettleton, J.A. and Folsom, A.R., Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Am. Heart. J. 2008, 156:965-974.
238. Yamazaki, R.K., Shen, T. and Schade, G.B., A diet rich in (n-3) fatty acids increases peroxisomal beta-oxidation activity and lowers plasma triacylglycerols without inhibiting glutathione-dependent detoxication activities in the rat liver. Biochim. Biophys. Acta 1987, 920:62-67.
239. Yanagisawa, A., Matsukura, T., Aoki, N., Miyagawa, M., Satoh, K., Metori, K., Mineo, S. and Ishikawa, K., Protection of the rat myocardium from ischemic injury by dietary lamprey oil. Eicosanoids 1988, 1:93-100.
240. Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S,, Sasaki, J., Hishida, H., Itakura, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, K. and Shirato, K., Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open- label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
241. Zheng, Z.J., Croft, J.B., Giles, W.H. and Mensah, G.A., Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001, 104:2158-2163.
242. Andersen, V.L., Vogt, J., Obel, T., Christensen, J.H., Schmidt, E.B., The effect of n-3 fatty acids on plasma myeloperoxidase levels in healthy adults. Cell. Mol. Biol. 2010, 56(1): 3-9.
243. Andreasen, J. J., Aardestrup, I. V., Eschen, R. B., Obel, T., Lundbye-Christensen, S., Schmidt, E. B., Fatty acid composition of the internal mammary artery in relation to dietary intake of marine n-3 polyunsaturated fatty acids and association with flow-mediated vasodilation. Cell. Mol. Biol. 2010, 56(1): 10-17.
244. Arnesen, H., Seljeflot, I., Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation. Cell. Mol. Biol. 2010, 56(1): 18-27.
245. Calder, P.C., Yaqoob, P., Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell. Mol. Biol. 2010, 56(1): 28-37.
246. Petersen, M.M., Eschen, R.B., Aardestrup, I., Obel, T., Schmidt, E.B., Flow-mediated vasodilation and dietary intake of n-3 polyunsaturated acids in healthy subjects. Cell. Mol. Biol. 2010, 56(1): 38-44.
247. Eschen, O., Christensen, J.H., La rovere, M.T., Romano, P., Sala, P., Schmidt, E.B., Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure. Cell. Mol. Biol. 2010, 56(1): 45-51.
248. Isherwood, C., Wong, M., Jones, W.S., Davies, I.G., Griffin, B.A., lack of effect of cold water prawns on plasma cholesterol and lipoproteins in normo-lipidaemic men. Cell. Mol. Biol. 2010, 56(1): 52-58.
249. Massaro, M., Scoditti, E., Carluccio, M. A., Campana, M. C., De caterina, R., Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils. Cell. Mol. Biol. 2010, 56(1): 59-82.
250. Mori, T. A., Omega-3 fatty acids and blood pressure. Cell. Mol. Biol. 2010, 56(1): 83-92.
251. Von Schacky, C., Omega-3 fatty acids vs. cardiac disease - the contribution of the omega-3 index. Cell. Mol. Biol. 2010, 56(1): 93-101.
252. 2-macroglobulin in healthy subjects after supplementation with different doses of marine n-3 fatty acids. Cell. Mol. Biol. 2010, 56(1): 102-109.
253. Christensen, J.H., Svensson, M., Strandhave, C, Madsen, T., Schmidt, E.B., N-3 fatty acids and cardiac autonomic function in humans. Cell. Mol. Biol. 2010, 56(1): 131-139.